Al-Jazeerah: Cross-Cultural Understanding
www.ccun.org www.aljazeerah.info |
News, May 2020 |
|||||||||||||||||||||||
Archives Mission & Name Conflict Terminology Editorials Gaza Holocaust Gulf War Isdood Islam News News Photos Opinion Editorials US Foreign Policy (Dr. El-Najjar's Articles) www.aljazeerah.info
|
287,621 Deaths, 4,273,104 Corona Virus Infections, Mostly in the US, UK, Italy, Spain, France, Brazil, Belgium, Germany, and the Netherlands May 12, 2020
World 4,273,104 infection cases, and 287,621 deaths. As of May 012, 2020, 10:52 GMT A list of countries with the highest and lowest Coronavirus (Covid-19) deaths: USA 1,385,850 cases, 81,795 deaths. UK 223,060 cases, 32,065 deaths. Italy 219,814 cases, 30,739 deaths. Spain 268,143 cases, 26,744 deaths. France 177,423 cases, 26,643 deaths. Brazil 169,594 cases, 11,653 deaths. Belgium 53,779 cases, 8,761 deaths. Germany 172,576 cases, 7,661 deaths. Netherlands 42,788 cases, 5,456 deaths. Chile 30,063 cases, 323 deaths. Saudi Arabia 41,014 cases, 255 deaths. South Africa 10,652 cases, 206 deaths. Nigeria 4,641 cases, 150 deaths. Belarus 23,906 cases, 135 deaths. Kuwait 9,286 cases, 65 deaths. Ghana 4,700 cases, 22 deaths. https://www.worldometers.info/coronavirus/ *** WHO Director-General's opening remarks at the media briefing on COVID-19 11 May 2020, ÇáÚÑÈíÉ, 中文 Good morning, good afternoon and good evening. *** Anthony Fauci Says More than One Coronavirus Vaccine Needed to End Pandemic By Aila Slisco Newsweek, May 12, 2020 Dr. Anthony Fauci and other leading health experts have suggested that more than one vaccine may be needed to effectively combat the COVID-19 pandemic due to production limitations and overwhelming demand. Fauci co-authored a paper published in the journal Science on Monday, suggesting that demand for an effective coronavirus vaccine is likely to far exceed supplies of any single vaccine. The White House coronavirus task force member wrote the paper alongside Fred Hutchison Cancer Research Center's Dr. Larry Corey and colleagues at the National Institutes of Health (NIH), including NIH Director Dr. Francis Collins and vaccine expert Dr. John Mascola. "There is an unprecedented need to manufacture and distribute enough safe and effective vaccine to immunize an extraordinarily large number of individuals," the paper states. "No single vaccine or vaccine platform alone is likely to meet the global need, and so a strategic approach to the multi-pronged endeavor is absolutely critical." While several vaccines for the virus are currently in development, scientists have cautioned that developing even a single effective vaccine presents a significant challenge. The delay between developing vaccines and making them available to the public is often years, although officials hope that a coronavirus vaccine will be available record time. A massive amount of funding has been provided for coronavirus vaccines and development is being aided by programs like NIH's "ACTIV" initiative, a partnership between government agencies and pharmaceutical companies aiming to accelerate the development of vaccines and therapies for COVID-19. Still, scientists believe additional funding may be needed to be successful on a global scale. "We want to see multiple successful vaccines and vaccine platforms meet the global need of immunizing billions of adults, children and restoring economic and health to the world," Corey said in a press release. The paper notes that there have been relatively few mutations of the spike-shaped protein that the virus uses to attach to cells, providing "cautious optimism" that any vaccines being developed now will still be effective when they are ready to be given to populations. Collins expects that multiple candidate vaccines will be successfully developed, potentially offering distinct benefits that could prove effective for different people. "My expectation is, and I am a bit of an optimist, that we don't find out that there's only one of these vaccines that works, but rather two or three of them come through the trials looking as though they're safe and effective," Collins told Bloomberg on Monday. "They'll have somewhat different characteristics of where they work best, so we might need to do some matching then of which vaccine goes to which particular population." However, any effective vaccines that are developed will require "the vaccine-manufacturing capacity of the entire world" to meet demand posed by the pandemic, the paper says. Newsweek reached out to Fauci for additional comment. This article will be updated with any response. *** Share the link of this article with your facebook friendsFair Use Notice This site contains copyrighted material the
use of which has not always been specifically authorized by the copyright
owner. We are making such material available in our efforts to advance
understanding of environmental, political, human rights, economic,
democracy, scientific, and social justice issues, etc. We believe this
constitutes a 'fair use' of any such copyrighted material as provided for
in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.
Section 107, the material on this site is
distributed without profit to those
who have expressed a prior interest in receiving the included information
for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml.
If you wish to use copyrighted material from this site for purposes of
your own that go beyond 'fair use', you must obtain permission from the
copyright owner.
|
|
Opinions expressed in various sections are the sole responsibility of their authors and they may not represent Al-Jazeerah & ccun.org. editor@aljazeerah.info & editor@ccun.org |